What is myLAB Box?
myLAB Box operates as a pivotal player in the health-tech landscape, providing a comprehensive suite of at-home wellness and diagnostic testing kits. By bypassing traditional clinical bottlenecks, the company offers a discreet, efficient, and highly accessible alternative for screening conditions ranging from sexual health and fertility to general wellness and toxicology. The firm leverages a network of certified laboratories to ensure that its remote testing solutions maintain clinical-grade accuracy. This model effectively addresses the growing consumer demand for privacy and convenience, positioning myLAB Box as a leader in the shift toward patient-centric, decentralized healthcare delivery systems.
How much funding has myLAB Box raised?
myLAB Box has raised a total of $3.2M across 3 funding rounds:
Other Financing Round
$560K
Private Equity
$1.1M
Angel/Seed
$1.6M
Other Financing Round (2015): $560K with participation from Houston Angel Network, K5 Ventures, Texas Halo Fund, Houston Health Ventures, and Pipeline Angels
Private Equity (2017): $1.1M, investors not publicly disclosed
Angel/Seed (2018): $1.6M, investors not publicly disclosed
Key Investors in myLAB Box
Houston Angel Network
The Houston Angel Network is a nonprofit organization focused on enhancing the innovation ecosystem in Houston, providing financial resources and mentorship to support founders and startups.
K5 Ventures
K5 Ventures is an early-stage startup accelerator and venture capital fund based in California, focusing on game-changing innovations and funding for exceptional products and teams.
Texas Halo Fund
Texas HALO Fund, LLC is an investment company specializing in early-stage investments in businesses with promising growth prospects and exceptional management teams.
What's next for myLAB Box?
The infusion of capital from this major strategic investment provides the necessary runway for myLAB Box to accelerate its operational scaling and product diversification. As the company transitions from its early-stage development into a more mature enterprise-level phase, the focus will likely shift toward enhancing its digital health platform and deepening its integration with physician-led consultation services. By optimizing its supply chain and expanding its diagnostic portfolio, the firm is well-positioned to capture a larger share of the remote health market, potentially setting new benchmarks for how diagnostic services are delivered in a post-pandemic environment.
See full myLAB Box company page
